Co‐administration of probiotic and vitamin D significantly improves cognitive function in schizophrenic patients: A double‐blinded randomized controlled trial - Mohammadi, Aida; Sadighi, Gita; Nazeri Astaneh, Ali; Tajabadi‐Ebrahimi, Maryam; Dejam, Tahereh (Neuropsychopharmacology reports, 2024)
Keywords: Adolescent; Adult; Aged; Antipsychotics; Body mass index; Brain research; Cholesterol; Clinical trials; Cognition - drug effects; Cognition - physiology; Cognitive ability; cognitive function; Dietary Supplements; Disease; Dopamine; Double-Blind Method; Female; High density lipoprotein; Humans; Informed consent; Lipids; Male; Medical research; Mental disorders; Mental health; Microbiota; Middle Aged; Original; Probiotics; Probiotics - administration & dosage; Psychotropic drugs; Sample size; Schizophrenia; Schizophrenia - blood; Schizophrenia - complications; Schizophrenia - drug therapy; Schizophrenic Psychology; Vitamin D; Vitamin D - administration & dosage; Vitamin D - blood; Vitamin D - therapeutic use; Vitamin deficiency; Young Adult; Iran; cognitive function; schizophrenia; vitamin D; probiotics